Intervention not reported
Cohort study ‐ Raven 5th year, MMR · children 9 months to 15 years old
The intervention showed no clear difference in cohort study ‐ Raven 5th year, MMR (low certainty).
1 finding from 1 review
Intervention not reported
Cohort study ‐ WISC‐R verbal 6th year, MMR · children 9 months to 15 years old
The intervention showed no clear difference in cohort study ‐ WISC‐R verbal 6th year, MMR (low certainty).
1 finding from 1 review
Intervention not reported
Case‐control ‐ case cross‐over ‐ case controls MMR · children 9 months to 15 years old
The intervention may leads to higher case‐control ‐ case cross‐over ‐ case controls MMR (low certainty).
1 finding from 1 review
Intervention not reported
Self‐controlled case series ‐ MMR vaccine ‐ age from 9 to 23 months · children 9 months to 15 years old
The intervention probably leads to higher self‐controlled case series ‐ MMR vaccine ‐ age from 9 to 23 months (moderate certainty).
1 finding from 1 review
Intervention not reported
Cohort studies ‐ Jeryl Lynn strain ‐ 2 doses · children 9 months to 15 years old
The intervention probably leads to lower cohort studies ‐ Jeryl Lynn strain ‐ 2 doses (moderate certainty).
1 finding from 1 review
Intervention not reported
Case‐control ‐ MMR vaccine · children 9 months to 15 years old
The intervention may leads to higher case‐control ‐ MMR vaccine (low certainty).
1 finding from 1 review
Intervention not reported
Cohort study MMR ‐ all children · children 9 months to 15 years old
The intervention showed no clear difference in cohort study MMR ‐ all children (low certainty).
1 finding from 1 review
Intervention not reported
Cohort study MMR ‐ children with at least 1 sibling with type 1 diabetes · children 9 months to 15 years old
The intervention showed no clear difference in cohort study MMR ‐ children with at least 1 sibling with type 1… (low certainty).
1 finding from 1 review
Intervention not reported
Cohort study (rate ratio) ‐ all ages · children 9 months to 15 years old
The intervention showed no clear difference in cohort study (rate ratio) ‐ all ages (low certainty).
1 finding from 1 review
Intervention not reported
Cohort studies (risk ratio) ‐ all ages · children 9 months to 15 years old
The intervention showed no clear difference in cohort studies (risk ratio) ‐ all ages (low certainty).
1 finding from 1 review
Intervention not reported
Cohort study (rate ratio) · children 9 months to 15 years old
It is very uncertain whether the intervention changes cohort study (rate ratio) (very low certainty).
1 finding from 1 review
Intervention not reported
Cohort study (risk ratio) · children 9 months to 15 years old
The intervention showed no clear difference in cohort study (risk ratio) (low certainty).
1 finding from 1 review
Intervention not reported
Cohort study ‐ rhinoconjunctivitis · children 9 months to 15 years old
The intervention showed no clear difference in cohort study ‐ rhinoconjunctivitis (low certainty).
1 finding from 1 review
Intervention not reported
Cohort study ‐ hypersensitivity/allergy · children 9 months to 15 years old
The intervention showed no clear difference in cohort study ‐ hypersensitivity/allergy (low certainty).
1 finding from 1 review
Intervention not reported
Case control ‐ hay fever · children 9 months to 15 years old
The intervention showed no clear difference in case control ‐ hay fever (low certainty).
1 finding from 1 review
Intervention not reported
Cohort studies ‐ Jeryl Lynn strain ‐ unspecified number of doses · children 9 months to 15 years old
The intervention may leads to lower cohort studies ‐ Jeryl Lynn strain ‐ unspecified number of doses (low certainty).
1 finding from 1 review
Intervention not reported
Case‐control ‐ acute leukaemia · children 9 months to 15 years old
The intervention showed no clear difference in case‐control ‐ acute leukaemia (low certainty).
1 finding from 1 review
Intervention not reported
Case‐control ‐ acute lymphoblastic leukaemia · children 9 months to 15 years old
The intervention showed no clear difference in case‐control ‐ acute lymphoblastic leukaemia (low certainty).
1 finding from 1 review
Intervention not reported
Case‐control ‐ acute myeloblastic leukaemia · children 9 months to 15 years old
The intervention showed no clear difference in case‐control ‐ acute myeloblastic leukaemia (low certainty).
1 finding from 1 review
Intervention not reported
Case‐control ‐ multiple sclerosis · children 9 months to 15 years old
The intervention showed no clear difference in case‐control ‐ multiple sclerosis (low certainty).
1 finding from 1 review